Profil
Karoline Shair currently works at Massachusetts Bar Association, as Member.
Dr. Shair also formerly worked at Millennium Pharmaceuticals, Inc., as Vice President & Region Head-Intellectual Property from 2015 to 2016, Biogen, Inc., as VP & Head Counsel-Intellectual Property Program from 2017 to 2019, FORMA Therapeutics, Inc., as Secretary & Vice President-Legal from 2016 to 2017, Takeda Pharmaceuticals U.S.A., Inc., as Vice President, and Akouos, Inc., as Head-Legal.
Dr. Shair received her undergraduate degree from Bryn Mawr College, doctorate degree from Yale University, and graduate degree from Boston College Law School.
Postes actifs de Karoline Shair
| Sociétés | Poste | Début |
|---|---|---|
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Corporate Officer/Principal | - |
Anciens postes connus de Karoline Shair
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2019 |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Conseiller Juridique Général | 01/07/2017 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/07/2016 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
| AKOUOS | Conseiller Juridique Général | - |
Formation de Karoline Shair
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Bryn Mawr College
Bryn Mawr College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Commercial Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
















